Investigating the feasibility of differentiating MS active lesions from inactive ones using texture analysis and

Farshad Shekari1, Alireza Vard2, Iman Adibi3

  • 1Department of Bioelectrics and Biomedical Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran; Student Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Insights

Texture analysis of diffusion-weighted imaging (DWI) with machine learning accurately differentiates active from inactive multiple sclerosis (MS) lesions, avoiding gadolinium-based contrast agents (GBCAs). This offers a safer, effective method for MS diagnosis and monitoring.

Area of Science:

  • Radiology
  • Neuroimaging
  • Machine Learning

Background:

  • Magnetic resonance imaging (MRI) with gadolinium-based contrast agents (GBCAs) is standard for active multiple sclerosis (MS) lesion detection.
  • Concerns exist regarding long-term GBCA accumulation in the body.
  • Alternative methods for MS lesion characterization are needed.

Purpose of the Study:

  • To investigate texture analysis in diffusion-weighted imaging (DWI) combined with machine learning.
  • To discriminate active from inactive MS lesions without using GBCAs.

Main Methods:

  • Developed an image processing pipeline for DWI lesion segmentation and quantization.
  • Extracted texture features and applied a two-stage feature reduction (t-test, PCA, SFS, SBS, ReliefF).
  • Utilized five classifiers (LR, SVM, DT, KNN, LDA) with 5-fold cross-validation.

Main Results:

  • Analyzed 255 MS lesions from 34 patients.
  • Identified 63 statistically significant texture features (P<0.05) differentiating active/inactive lesions.
  • Achieved highest performance with SVM and PCA: 0.960 accuracy, 1.0 specificity/precision, 0.913 sensitivity, 0.957 AUC.

Conclusions:

  • DWI texture analysis and machine learning models accurately differentiate active from inactive MS lesions.
  • This approach provides valuable clinical data for early MS diagnosis and monitoring.
  • Offers a GBCA-free method for MS lesion characterization.

Related Concept Videos